PubMed Health⌕ Search

Biomedical subjects

Naoki Nakamura

Publications and source records attributed to Naoki Nakamura.

21 records · Page 2Linked to original sources

Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma.

OBJECT: Nonfunctioning pituitary adenomas comprise approximately 30% of all pituitary tumors. The purpose of this retrospective study is to evaluate the efficacy and role of gamma knife radiosurgery (GKS) in the management of residual or recurrent nonfunctioning pituitary adenomas. METHODS: A review was conducted of the data obtained in 42 patients who underwent adjuvant GKS at the University of Pittsburgh between 1987 and 2001. Prior treatments included transsphenoidal resection, craniotomy and resection, or conventional radiotherapy. Endocrinological, ophthalmological, and radiological responses were evaluated. The duration of follow-up review varied from 6 to 102 months (mean 31.2 months). Fifteen patients were observed for more than 40 months. The mean radiation dose to the tumor margin was 16 Gy. Conformal radiosurgery planning was used to restrict the dose to the optic nerve and chiasm. Tumor control after GKS was achieved in 100% of patients with microadenomas and 97% of patients with macroadenomas. Gamma knife radiosurgery was equally effective in controlling adenomas with cavernous sinus invasion and suprasellar extension. No patient developed a new endocrinological deficiency following GKS. One patient's tumor enlarged with an associated decline in visual function. Another patient experienced a deterioration of visual fields despite a decrease in tumor size. CONCLUSIONS: Gamma knife radiosurgery can achieve tumor control in virtually all residual or recurrent nonfunctioning pituitary adenomas. Dose sparing facilitates tumor management even when the adenoma is close to the optic apparatus or invades the cavernous sinus.

Adenoma↗

Intercomparison of dose distribution between gamma knife and C-arm-mounted linac.

Although the Gamma Knife is widely used as a standard tool of radiosurgery for intracranial diseases, recent innovations in medical accelerators have actualized equivalent dose distribution. Most commonly, multiple non-coplanar arc beams through a combination of gantry and couch rotations are used in linac-based radiosurgery, but beam entry geometry is different from that with the Gamma Knife. We have developed a C-arm-mounted medical accelerator and realized conical beam entry without couch rotation. A combination of several conical rotation beams with different C-arm angles comprises multi-orbit dynamic conical radiation therapy (MODCRT) and resembles radiation beam entry with the Gamma Knife. Intercomparison of dose distributions and dose-volume histograms for the same brain tumor demonstrated that MODCRT delivers a similar dose fall-off pattern to that obtained with the Gamma Knife, though the low-dose spread patterns differ.

Brain Neoplasms↗

The intergroup/RTOG 85-01 concurrent chemoradiation regimen for Japanese esophageal cancer.

BACKGROUND/AIMS: To evaluate outcome of the U.S. RTOG/Intergroup Protocol 85-01 for 44 Japanese esophageal cancer patients. METHODOLOGY: Between 1996 and 2004, patients with esophageal cancer received the Intergroup concurrent chemoradiation therapy regimen for the primary treatment (n=44, group A). We compared the data with those of patients receiving radiotherapy (RT) combined with the weekly chemotherapy regimen (n=12, group B) and with those of patients receiving RT combined with the daily low-dose chemotherapy regimen (n=24, group C). RESULTS: The median survival period was 14.9 months in group A, 5.7 months in group B, and 6.3 months in group C. The survival rates at 1 and 3 years were 56% and 26% in group A, 42% and 21% in group B (p=0.3307), and 27% and 18% in group C (p=0.0462), respectively. CONCLUSIONS: The prognosis of patients who received the Intergroup regimen for esophageal cancer was significantly better than that of patients who received the daily low-dose chemotherapy regimen. The Intergroup regimen is well tolerable for the Japanese patients too.

Adult↗